You are here

China vaccine maker applies for public use of Covid shot

rk_CNBG_251120.jpg
China National Biotec Group (CNBG) has submitted an application to Chinese regulators, reported state media Xinhua Finance on Wednesday, citing parent company Sinopharm's vice-general manager Shi Shengyi. The application likely includes interim data from the company's Phase III human testing conducted in the Middle East and South America.

[BEIJING] A leading Chinese vaccine developer has applied for authorisation to bring its Covid-19 shot to the market, seeking to get a jump on Western rivals as the race for a working inoculation against the virus enters the final stretch.

China National Biotec Group (CNBG) has submitted...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes